Suzuki T, Ishida R, Matsui S, Masubuchi Y, Narimatzu S
Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Chiba University, Japan.
Biochem Pharmacol. 1993 Apr 6;45(7):1528-30. doi: 10.1016/0006-2952(93)90055-2.
The metabolic interaction between lidocaine (LD) and propranolol (PL) was analysed kinetically in rat liver microsomes. Employing a very short incubation time of 30 sec, we demonstrated that PL competitively inhibited liver microsomal 3-hydroxylation of LD, but did not affect either the formation of monoethylglycinexylidide or methylhydroxylidocaine from LD in PL concentrations up to 1 microM. On the other hand, LD competitively inhibited PL 4-, 5- and 7-hydroxylations, but the inhibition type of LD for PL N-desisopropylation could not be clarified. Comparison of the kinetic data for liver microsomes from Wistar and Dark Agouti rats indicated that among the primary metabolic pathways of LD, the Vmax value for 3-hydroxylation was markedly less in female Dark Agouti rats. The results suggest that LD 3-hydroxylation and PL ring hydroxylations are mediated by the same isozyme(s) belonging to the CYP2D subfamily.
在大鼠肝微粒体中对利多卡因(LD)和普萘洛尔(PL)之间的代谢相互作用进行了动力学分析。采用30秒的极短孵育时间,我们证明PL竞争性抑制LD的肝微粒体3-羟基化,但在PL浓度高达1 microM时,对LD生成单乙基甘氨酰二甲苯或甲基羟基利多卡因均无影响。另一方面,LD竞争性抑制PL的4-、5-和7-羟基化,但LD对PL N-去异丙基化的抑制类型尚不清楚。对Wistar大鼠和深色刺豚鼠肝微粒体的动力学数据比较表明,在LD的主要代谢途径中,雌性深色刺豚鼠3-羟基化的Vmax值明显较低。结果表明,LD的3-羟基化和PL的环羟基化由属于CYP2D亚家族的同一种同工酶介导。